Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Clinical trial NCT05188170 · RECRUITING
Trial details
- NCT number
- NCT05188170
- Sponsor
- Stanford University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2026-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.